Literature DB >> 28983099

Breaking barriers to novel analgesic drug development.

Ajay S Yekkirala, David P Roberson, Bruce P Bean, Clifford J Woolf.   

Abstract

This corrects the article DOI: 10.1038/nrd.2017.87.

Entities:  

Year:  2017        PMID： 28983099      PMCID： PMC6934078          DOI： 10.1038/nrd.2017.202

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


  1 in total

Review 1.  Breaking barriers to novel analgesic drug development.

Authors:  Ajay S Yekkirala; David P Roberson; Bruce P Bean; Clifford J Woolf
Journal:  Nat Rev Drug Discov       Date:  2017-06-09       Impact factor: 84.694
  1 in total
  18 in total

1.  The specialised pro-resolving lipid mediator maresin 1 reduces inflammatory pain with a long-lasting analgesic effect.

Authors:  Victor Fattori; Felipe A Pinho-Ribeiro; Larissa Staurengo-Ferrari; Sergio M Borghi; Ana C Rossaneis; Rubia Casagrande; Waldiceu A Verri
Journal:  Br J Pharmacol       Date:  2019-04-15       Impact factor: 8.739

Review 2.  Targeting the blood-nerve barrier for the management of immune-mediated peripheral neuropathies.

Authors:  Evan B Stubbs
Journal:  Exp Neurol       Date:  2020-06-17       Impact factor: 5.330

Review 3.  Two-pore domain potassium channels: emerging targets for novel analgesic drugs: IUPHAR Review 26.

Authors:  Kirin Gada; Leigh D Plant
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

4.  Measuring Mouse Somatosensory Reflexive Behaviors with High-speed Videography, Statistical Modeling, and Machine Learning.

Authors:  Ishmail Abdus-Saboor; Wenqin Luo
Journal:  Neuromethods       Date:  2022-05-27

5.  OREX-1038: a potential new treatment for pain with low abuse liability and limited adverse effects.

Authors:  Lisa R Gerak; David R Maguire; Gerta Cami-Kobeci; Keith M Olson; John R Traynor; Stephen M Husbands; Charles P France; Lisette Acevedo; Barbara Belli; Peter Flynn
Journal:  Behav Pharmacol       Date:  2022-08-03       Impact factor: 2.277

6.  The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain.

Authors:  Moritz Möller; Christine V Möser; Ulrike Weiß; Ellen Niederberger
Journal:  Cells       Date:  2022-06-19       Impact factor: 7.666

7.  Targeting intrinsically disordered regions facilitates discovery of CaV3.2 inhibitory peptides for AAV-mediated peripheral analgesia.

Authors:  Seung Min Shin; Justas Lauzadis; Brandon Itson-Zoske; Yongsong Cai; Fan Fan; Gayathri Natarajan; Wai-Meng Kwok; Michelino Puopolo; Quinn H Hogan; Hongwei Yu
Journal:  Pain       Date:  2022-04-14       Impact factor: 7.926

8.  Recurrent antinociception induced by intrathecal or peripheral oxytocin in a neuropathic pain rat model.

Authors:  Abimael González-Hernández; Antonio Espinosa De Los Monteros-Zuñiga; Guadalupe Martínez-Lorenzana; Miguel Condés-Lara
Journal:  Exp Brain Res       Date:  2019-09-12       Impact factor: 1.972

9.  Front and hind paw differential analgesic effects of amitriptyline, gabapentin, ibuprofen, and URB937 on mechanical and cold sensitivity in cisplatin-induced neuropathy.

Authors:  Jeremy M Thompson; Henry L Blanton; Agata Pietrzak; William Little; Caitlyn Sherfey; Josée Guindon
Journal:  Mol Pain       Date:  2019 Jan-Dec       Impact factor: 3.395

Review 10.  eIF4E-Dependent Translational Control: A Central Mechanism for Regulation of Pain Plasticity.

Authors:  Sonali Uttam; Calvin Wong; Theodore J Price; Arkady Khoutorsky
Journal:  Front Genet       Date:  2018-10-24       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.